請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62121
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李繼忠,季匡華 | |
dc.contributor.author | Hong-Wei Yeo | en |
dc.contributor.author | 楊鴻偉 | zh_TW |
dc.date.accessioned | 2021-06-16T13:28:54Z | - |
dc.date.available | 2014-08-08 | |
dc.date.copyright | 2013-08-08 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-07-22 | |
dc.identifier.citation | 1. Chou, T., Chou, H., Cheng, C., Yeh, L., 2011. Retrospective survey of surgical excision of feline vaccine-associated sarcoma: 57 cases (2002-2009). Taiwan Veterinary Journal 37, 53-62.
2. Cohen, M., Wright, J.C., Brawner, W.R., Smith, A.N., Henderson, R., Behrend, E.N., 2001. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996-2000). Journal of the American Veterinary Medical Association 219, 1582-1589. 3. Couto, S.S., Griffey, S.M., Duarte, P.C., Madewell, B.R., 2002. Feline vaccine-associated fibrosarcoma: Morphologic distinctions. Veterinary Pathology 39, 33-41. 4. Cronin, K., Page, R.L., Spodnick, G., Dodge, R., Hardie, E.N., Price, G.S., Ruslander, D., Thrall, D.E., 1998. Radiation therapy and surgery for fibrosarcoma in 33 cats. Veterinary Radiology & Ultrasound 39, 51-56. 5. Davidson, E.B., Gregory, C.R., Kass, P.H., 1997. Surgical excision of soft tissue fibrosarcomas in cats. Veterinary Surgery 26, 265-269. 6. Doddy, F.D., Glickman, L.T., Glickman, N.W., Janovitz, E.B., 1996. Feline fibrosarcomas at vaccination sites and non-vaccination sites. Journal of Comparative Pathology 114, 165-174. 7. Eckstein, C., Guscetti, F., Roos, M., Martin de las Mulas, J., Kaser-Hotz, B., Rohrer Bley, C., 2009. A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcoma. Vet Comp Oncol 7, 54-68. 8. Farrelly, J., McEntee, M.C., 2003. Principles and applications of radiation therapy. Clin Tech Small Anim Pract 18, 82-87. 9. Fowler, J.F., 2010. 21 years of biologically effective dose. Br J Radiol 83, 554-568. 10. Giudice, C., Stefanello, D., Sala, M., Cantatore, M., Russo, F., Romussi, S., Travetti, O., Di Giancamillo, M., Grieco, V., 2010. Feline injection-site sarcoma: recurrence, tumour grading and surgical margin status evaluated using the three-dimensional histological technique. Vet J 186, 84-88. 11. Hendrick, M.J., Brooks, J.J., 1994. Postvaccinal Sarcomas in the Cat - Histology and Immunohistochemistry. Veterinary Pathology 31, 126-129. 12. Hendrick, M.J., Dunagan, C.A., 1991. Focal Necrotizing Granulomatous Panniculitis Associated with Subcutaneous Injection of Rabies Vaccine in Cats and Dogs - 10 Cases (1988-1989). Journal of the American Veterinary Medical Association 198, 304-305. 13. Hendrick, M.J., Goldschmidt, M.H., 1991. Do Injection Site Reactions Induce Fibrosarcomas in Cats. Journal of the American Veterinary Medical Association 199, 968-968. 14. Hendrick, M.J., Kass, P.H., Mcgill, L.D., Tizard, I.R., 1994. Postvaccinal Sarcomas in Cats. Journal of the National Cancer Institute 86, 341-343. 15. Hershey, A.E., Sorenmo, K.U., Hendrick, M.J., Shofer, F.S., Vail, D.M., 2000. Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996). J Am Vet Med Assoc 216, 58-61. 16. Kass, P.H., Barnes, W.G., Spangler, W.L., Chomel, B.B., Culbertson, M.R., 1993. Epidemiologic Evidence for a Causal Relation between Vaccination and Fibrosarcoma Tumorigenesis in Cats. Journal of the American Veterinary Medical Association 203, 396-405. 17. Kass, P.H., Spangler, W.L., Hendrick, M.J., McGill, L.D., Esplin, D.G., Lester, S., Slater, M., Meyer, E.K., Boucher, F., Peters, E.M., Gobar, G.G., Htoo, T., Decile, K., 2003. Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 223, 1283-1292. 18. Kobayashi, T., Hauck, M.L., Dodge, R., Page, R.L., Price, G.S., Williams, L.E., Hardie, E.M., Mathews, K.G., Thrall, D.E., 2002. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Veterinary Radiology & Ultrasound 43, 473-479. 19. Martano, M., Morello, E., Buracco, P., 2011. Feline injection-site sarcoma: past, present and future perspectives. Vet J 188, 136-141. 20. Mayer, M.N., Treuil, P.L., LaRue, S.M., 2009. Radiotherapy and Surgery for Feline Soft Tissue Sarcoma. Veterinary Radiology & Ultrasound 50, 669-672. 21. McEntee, M.C., 2006. Veterinary radiation therapy: review and current state of the art. J Am Anim Hosp Assoc 42, 94-109. 22. McEntee, M.C., Page, R.L., 2001. Feline vaccine-associated sarcomas. Journal of Veterinary Internal Medicine 15, 176-182. 23. McNiel, E.A., 2001. Vaccine-associated sarcomas in cats: a unique cancer model. Clin Orthop Relat Res, 21-27. 24. Phelps, H.A., Kuntz, C.A., Milner, R.J., Powers, B.E., Bacon, N.J., 2011. Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002). Javma-Journal of the American Veterinary Medical Association 239, 97-106. 25. Romanelli, G., Marconato, L., Olivero, D., Massari, F., Zini, E., 2008. Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007). Javma-Journal of the American Veterinary Medical Association 232, 1193-1199. 26. Seguin, B., 2002. Feline injection site sarcomas. Veterinary Clinics of North America-Small Animal Practice 32, 983-+. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62121 | - |
dc.description.abstract | 貓注射部位肉瘤(Feline injection-site sarcomas, FISS),又稱為貓疫苗相關肉瘤(feline vaccine-associated sarcomas, VAS),是貓最常見的皮下腫瘤,約佔所有貓皮膚腫瘤的40%。FISS是一個局部侵犯性高,生長快速,但遠端移轉率低,且有時有較長的潛伏期。由於其局部復發機率非常高,因此合併使用多種治療方法是目前建議的治療方式,其中包括手術切除、放射治療和化學治療。手術前或手術後加上輔助性放射治療(Adjuvant radiation therapy)仍然是達到腫瘤長時期控制最理想的治療方式。低分次放射治療(Hypofractionated radiation therapy)是將照射劑量由傳統單次200 cGy左右的劑量調高,總次數減少的方式給予,此方式不僅可以減少動物接受麻醉的次數,更能創造更高的生物效應。然而,在FISS使用低分次放射治療的治療效果仍不明確。因此,本篇研究回溯性討論在FISS使用手術切除合併輔助性低分次放射治療的臨床經驗。結果顯示單接受手術治療組的局部腫瘤復發率為57% (12/21),而接受手術切除合併輔助性低分次放射治療組的局部腫瘤復發率為21% (3/14) (P=0.039)。單接受手術治療組的中位數無病時間為338天,而接受手術切除合併輔助性低分次放射治療組的中位數無病時間為609天(P=0.104)。貓接受保守切除的中位數無病時間為192天,而接受大範圍切除或徹底切除的中位數無病時間為844天(P=0.001)。比較原始腫塊大小≤3公分和>3公分的中位數無病時間有顯著差異,其中位數無病時間分別為1053天和337天(P=0.04)。此外,原始腫塊大小>3公分的局部腫塊復發率為原始腫塊大小≤3公分的6倍,因此原始腫塊大小或許能作為預後因子之一。術前或術後接受輔助性低分次放射治療的中位數無病時間,並無顯著差異(P=0.479)。由此我們推論以大範圍或徹底的手術方式切除是治療FISS的主要方式之一,但單獨的手術治療仍有較高的局部腫塊復發率,因此手術切除合併輔助性低分次放射治療有助達到長時間的腫瘤控制,且治療效果和使用傳統的輔助性放射治療相似。 | zh_TW |
dc.description.abstract | Feline injection-site sarcomas (FISS) also known as vaccine-associated sarcomas (VAS) is the most common subcutaneous tumor in feline and accounts for about 40% of all feline skin tumors. FISS is highly local invasive in spite of a low metastatic rate with often rapidly growing and occasionally long latency period. A multimodal treatment protocol is recommended due to the high local recurrence rate. Pre- or post-surgery combined with adjuvant radiation therapy (RT) remains the ideal approach for those animals in which long-term control may be achieved. Hypofractionated RT is a treatment, in which larger single fraction dose (beyond conventional 200 cGy/fraction) was used with less fraction numbers that can decrease the frequency of anesthesia as well as increase the biological effect in less total dose. However, the clinical reports of adjuvant hypofractionated RT in FISS were limited. Therefore, we retrospectively review our experiences on hypofractionated RT combined with surgery in FISS. Result showed that local tumor recurrences were reported in 12 of 21 (57%) for surgery alone group and 3 of 14 (21%) cats for adjuvant hypofractionated RT group (P=0.039). The median disease free intervals (DFI) for surgery alone group and adjuvant hypofractionated RT group were 338 days (range, 7 to 364 days) and 609* days (range, 37 to 337 days), respectively (P = 0.104). Median DFI in cats receiving conservative surgery was 192 days compared to cats receiving wide margin or radical surgery where median DFI was 844* days (P=0.001). Median DFI in cats with primary tumor size ≤3 cm in diameter at greatest dimension was 1053* days compared to cats with primary tumor size >3 cm where median DFI was 337 days (P=0.04). We also found that primary tumor size >3 cm was 6 times in local tumor recurrence when compared with primary tumor size ≤3 cm; therefore tumor size might be one of the prognostic factors. There is no significant difference when compared DFI for cats receiving pre- or post-surgery adjuvant hypofractionated RT (P=0.479). We concluded that wide margin or radical surgery was mandatory for FISS; furthermore, surgery excision combined with adjuvant hypofractionated RT can achieve a similar long-term control rate when compared with conventional adjuvant RT in treating FISS. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T13:28:54Z (GMT). No. of bitstreams: 1 ntu-102-R99643001-1.pdf: 892356 bytes, checksum: 66ff87f7d5fcf9d2ffecd700650c86d3 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 誌謝 II
中文摘要 III Abstract V Table of Contents VIII List of Tables X List of Figures XI Chapter I Introduction 1 1.1 Feline injection-site sarcomas 1 1.2 The background of radiation therapy 4 1.3 Surgical excision of feline injection-site sarcomas 7 1.4 Radiation therapy of feline injection-site sarcomas 10 Chapter II Aim 14 Chapter III Methods & Materials 15 3.1 Study population 15 3.2 Tumor staging 15 3.3 Surgery procedure 16 3.4 Radiation therapy procedure 17 3.5 Statistical analysis 18 Chapter IV Result 20 4.1 Demographic 20 4.2 Surgery alone group 21 4.3 Adjuvant hypofractionated radiation therapy group 22 4.4 Statistical analysis 25 4.4.1 Compared two studies group 25 4.4.2 Adjuvant hypofractionated radiation therapy group 28 4.4.3 Surgery alone group 29 Chapter V Discussion 31 5.1 Efficacy 31 5.2 Influential factors evaluation 35 5.3 Limitation of this study 38 Chapter VI Conclusion 39 Tables and Figures 41 References 70 | |
dc.language.iso | en | |
dc.title | 以回溯性研究方式評估使用合併性低次分放射治療在貓注射部位肉瘤之效果 | zh_TW |
dc.title | Evaluation of Adjuvant Hypofractionated Radiation Therapy in Feline Injection-site Sarcomas: A Retrospective Study | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林辰栖,廖泰慶,蕭宏昇 | |
dc.subject.keyword | FISS,VAS,貓注射部位肉瘤,低分次放射治療,輔助性放射治療, | zh_TW |
dc.subject.keyword | FISS,VAS,Feline injection-site sarcomas,Adjuvant RT,Hypofractionated RT, | en |
dc.relation.page | 73 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-07-22 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 臨床動物醫學研究所 | zh_TW |
顯示於系所單位: | 臨床動物醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 871.44 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。